Buy GILD Now Before Its Next Breakout

Gilead Sciences (GILD) has a history of brief consolidations before making new highs. More 

The Market Is Faring No Better Than the Broncos

The market has taken a bit of a beating so far this year, however investors should take heart: companies that have managed to grow earnings are doing just fine More 

6 Biotechnology Stocks to Buy Now

The grades of six biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More 

Emerging Market Turmoil Gives Rally Frostbite

Emerging market turmoil and Apple stock's crash rule the headlines, but it's the ongoing earnings calendar that will eventually turn the stock market around. More 

Chart Predicts Top Biotech Is About to Break Out

It appears to be only a matter of time before Gilead Sciences (GILD) breaks to new highs. More 

The S&P’s Most Dramatic Performances of 2013 (And What They Taught Us)

We look at 2013's best and worst performers in the S&P 500, as well as what that might say about returns in 2014. More 

GILD: Get on While Biotech Remains Hot

The bulls seemingly are unwilling to cast off biotech. And among the sector's biggest stocks, Gilead Sciences (GILD) has the most appealing setup. More